Baillie Gifford - CHINOOK THERAPEUTICS INC ownership

CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 77 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of CHINOOK THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$17,824,767
+58.2%
463,945
-4.7%
0.02%
+50.0%
Q1 2023$11,264,674
-12.2%
486,595
-0.6%
0.01%
-23.1%
Q4 2022$12,830,350
+40.6%
489,708
+5.5%
0.01%
+44.4%
Q3 2022$9,128,000
+3.4%
464,314
-8.0%
0.01%0.0%
Q2 2022$8,829,000
-33.4%
504,825
-37.7%
0.01%0.0%
Q1 2022$13,266,000
-3.6%
810,879
-3.9%
0.01%
+12.5%
Q4 2021$13,762,000
+28.8%
843,812
+0.7%
0.01%
+33.3%
Q3 2021$10,688,000
-9.8%
837,576
-0.2%
0.01%0.0%
Q2 2021$11,852,000
-9.8%
839,380
-0.7%
0.01%
-14.3%
Q1 2021$13,139,000
-1.9%
845,485
+0.1%
0.01%0.0%
Q4 2020$13,397,000
+29.2%
844,684
-80.2%
0.01%0.0%
Q3 2020$10,366,0004,265,9800.01%
Other shareholders
CHINOOK THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 3,168,388$50,251,0005.05%
ATP Life Science Ventures, L.P. 4,028,937$63,859,0004.93%
Affinity Asset Advisors, LLC 150,000$2,379,0001.26%
Altium Capital Management LP 205,799$3,264,0001.22%
EcoR1 Capital, LLC 1,250,001$19,825,0001.07%
Vivo Capital, LLC 1,206,266$19,131,0000.85%
Marquette Asset Management, LLC 182,036$2,887,0000.66%
Monashee Investment Management LLC 272,949$4,329,0000.57%
Ally Bridge Group (NY) LLC 199,600$3,166,0000.54%
Rubric Capital Management LP 325,863$5,168,0000.38%
View complete list of CHINOOK THERAPEUTICS INC shareholders